OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of Neutropenic Murine Models of Iron Overload and Depletion To Study the Efficacy of Siderophore-Antibiotic Conjugates
James M. Kidd, Kamilia Abdelraouf, David P. Nicolau
Antimicrobial Agents and Chemotherapy (2019) Vol. 64, Iss. 1
Open Access | Times Cited: 15

Showing 15 citing articles:

Cefiderocol for the Treatment of Multidrug-Resistant Gram-Negative Bacteria: A Systematic Review of Currently Available Evidence
Chuanhai Wang, Deqing Yang, Yifan Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 39

Cefiderocol: Clinical application and emergence of resistance
Liang Wang, Jie Zhu, Liang Chen, et al.
Drug Resistance Updates (2023) Vol. 72, pp. 101034-101034
Closed Access | Times Cited: 12

Human Serum Proteins and Susceptibility of Acinetobacter baumannii to Cefiderocol: Role of Iron Transport
Casin Le, Camila Pimentel, Fernando Pasterán, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 600-600
Open Access | Times Cited: 17

Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson’s disease
Qinghui Wang, Jianing Liu, Yu Zhang, et al.
Redox Biology (2024) Vol. 77, pp. 103369-103369
Open Access | Times Cited: 3

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
Daniele Roberto Giacobbe, Eugenio Ciacco, Corrado Girmenia, et al.
Infection and Drug Resistance (2020) Vol. Volume 13, pp. 4697-4711
Open Access | Times Cited: 25

Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
Wesley D. Kufel, Jeffrey M. Steele, Scott W. Riddell, et al.
IDCases (2020) Vol. 21, pp. e00863-e00863
Open Access | Times Cited: 24

Clinical Pharmacokinetics and Pharmacodynamics of Cefiderocol
Muhammad Bilal, Lobna El Tabei, Sören Büsker, et al.
Clinical Pharmacokinetics (2021) Vol. 60, Iss. 12, pp. 1495-1508
Open Access | Times Cited: 22

Efficacy of Humanized Cefiderocol Exposure Is Unaltered by Host Iron Overload in the Thigh Infection Model
James M. Kidd, Kamilia Abdelraouf, David P. Nicolau
Antimicrobial Agents and Chemotherapy (2019) Vol. 64, Iss. 1
Open Access | Times Cited: 15

Human-Simulated Antimicrobial Regimens in Animal Models: Transparency and Validation Are Imperative
Christian M Gill, Tomefa E. Asempa, David P. Nicolau
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 8
Open Access | Times Cited: 12

Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study
Eric P. Skaar, Roger Echols, Yuko Matsunaga, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 3, pp. 467-476
Open Access | Times Cited: 5

In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples
Davide Carcione, Claudia Siracusa, Adela Sulejmani, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1309-1309
Open Access | Times Cited: 6

Bibliometric Review on New Possibilities of Antimycobacterial Agents: Exploring Siderophore Desferrioxamine’s Applications as an Antimicrobial Agent
Patrícia Vieira de Oliveira, Roseane de Santana Lira, Rafael de Abreu Lima, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1335-1335
Open Access | Times Cited: 2

Pharmacological and clinical profile of cefiderocol, a siderophore cephalosporin against gram-negative pathogens
Anselm Jorda, Markus Zeitlinger
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 7, pp. 777-791
Closed Access | Times Cited: 5

Impact of Human Serum Proteins on Susceptibility ofAcinetobacter baumanniito Cefiderocol: role of iron transport
Casin Le, Camila Pimentel, Fernando Pasterán, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access

Page 1

Scroll to top